Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases | Family Medicine
Clinical Trials: Asthma
A listing of clinical trials currently looking for volunteers to enroll in Asthma studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham :
A Non-drug Study Profiling Asthma
Birmingham : Teva Investigational Site 10165
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Birmingham : University of Alabama at Birmingham Lung Health Center
Bronchial Thermoplasty in Severe Persistent Asthma
Birmingham :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Birmingham : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Birmingham : Investigational Site 861
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Homewood : Investigational Site 842
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Jasper : Investigational Site 887
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Mobile : Pulmonary Associates of Mobile, P.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mobile : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Oxford :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Ozark : Call for Information (Investigational Site 0047) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Pell City :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Arizona
Phoenix : Research Site
A clinical research study for asthmatics 12 years and over.
Phoenix : Arizona Research Center
Asthma
Scottsdale : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Glendale : Call for Information (Investigational Site 9038) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Mesa : Call for Information (Investigational Site 0045) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Phoenix : Call for Information (Investigational Site 0055) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Phoenix : Phoenix Children's Hospital
A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children
Scottsdale : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Scottsdale :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Scottsdale : Teva Investigational Site 10104
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Scottsdale : Allergy & Immunology Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Scottsdale : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Tucson :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Tucson : University of Arizona
Diagnosis of Exercise-Induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes
Tucson : University of Arizona, Arizona Respiratory Center
Long-acting Beta Agonist Step Down Study
Tucson : Investigational Site 809
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Tucson : Investigational Site 892
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Arkansas
Little Rock : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Fort Smith : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Little Rock : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Little Rock : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Little Rock : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Little Rock : Investigational Site 846
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
California
Bell : Research Site
A clinical research study for asthmatics 12 years and over.
Canoga Park : Research Site
A clinical research study for asthmatics 12 years and over.
Costa Mesa : WCCT Global
Asthma Research Study
Costa Mesa : WCCT Global
Asthma Research Study
Encinitas : Research Site
A clinical research study for asthmatics 12 years and over.
Fountain Valley : Research Site
A clinical research study for asthmatics 12 years and over.
Fresno : Research Site
A clinical research study for asthmatics 12 years and over.
Huntington Park : Rx for Life, Inc.
Are you African-American? Do you have Asthma?
Long Beach : CNS Network
A Phase IV Study Investigating a New Combination Therapy for Persistent Asthma
Long Beach : Novo Research, Inc.
Adolescent and Adult Subjects with Asthma
Los Angelas : Research Site
A clinical research study for asthmatics 12 years and over.
Los Angeles : Research Site
A clinical research study for asthmatics 12 years and over.
Mission Viejo : Research Site
A clinical research study for asthmatics 12 years and over.
Orange : Research Site
A clinical research study for asthmatics 12 years and over.
Redwood City : Research Site
A clinical research study for asthmatics 12 years and over.
Rolling Hills Estates : Peninsula Research Associates, Inc.
Asthma - Ages 18 to 70, Up to $810 in compensation
San Gabriel : California Center for Clinical Research
A study evaluating inhalers for the treatment of Asthma in Adolescents and Adults.
San Jose : Research Site
A clinical research study for asthmatics 12 years and over.
Torrance : Research Site
A clinical research study for asthmatics 12 years and over.
Torrance : Research Site
A clinical research study for asthmatics 12 years and over.
Walnut Creek : Research Site
A clinical research study for asthmatics 12 years and over.
Westlake Village : Research Site
A clinical research study for asthmatics 12 years and over.
Wildomar : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Anaheim : Convergys Clinical Research, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Anaheim : Investigational Site 828
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Bakersfield :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Bakersfield :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Bakersfield : Teva Investigational Site 10573
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Bakersfield : Teva Investigational Site 10173
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Buena Park : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Costa Mesa : Teva Investigational Site 10163
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Costa Mesa : West Coast Clinical Trials
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
Cypress : West Coast Clinical Trials, LLC
Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults
Cypress : West Coast Clinical Trials Global
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Encinitas : Teva Investigational Site 10156
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Encinitas : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Encinitas : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Folsom : Site 1
WheezoMeter® Correlation Study
Fountain Valley : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Fountain Valley : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Fountain Valley :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Fountain Valley :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Fountain Valley : Call for Information (Investigational Site 0124)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Fountain Valley : Teva Investigational Site 10590
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Fountain Valley : Allianz Medical and Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Fresno : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Fresno : Research Center of Fresno, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Fresno : Research Center of Fresno
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Fresno : Investigational Site 900
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Fullerton : Call for Information (Investigational Site 0064) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Fullerton : California Research Medical Group, Inc
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Fullerton :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Fullerton :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Fullerton : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Granada Hills : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Granada Hills : Teva Investigational Site 10551
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Granada Hills : Teva Investigational Site 10151
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Granada Hills :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Huntington Beach : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Huntington Beach : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Huntington Beach : Allergy & Asthma Specialists Medical Group
A Study of ARRY-502 in Patients With Persistent Asthma
Huntington Beach : Teva Investigational Site 10157
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Huntington Beach : Teva Investigational Site 10176
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Huntington Beach : Pediatric Care Medical Group
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Huntington Beach : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Huntington Beach : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Huntington Beach : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Huntington Beach : Investigational Site 862
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Long Beach : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Long Beach :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Long Beach : Teva Investigational Site 10547
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Long Beach : Teva Investigational Site 10147
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Long Beach : West Coast Clinical Trials
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Long Beach : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Long Beach : Health Care Partners Medical Group
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Long Beach : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Los Angeles : GSK Investigational Site
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Los Angeles : California Allergy & Asthma Medical Group, INC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Los Angeles : Allergy Medical Clinic Research Division
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Los Angeles : Southern California Institute for Respiratory Diseases, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Los Angeles : Allergy Medical Clinic - Research Division
A Study of ARRY-502 in Patients With Persistent Asthma
Los Angeles : California Allergy & Asthma Med. Group
A Study of ARRY-502 in Patients With Persistent Asthma
Los Angeles : Southern California Institute for Respiratory Diseases Inc
A Study of ARRY-502 in Patients With Persistent Asthma
Los Angeles :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Los Angeles :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Los Angeles : California Allergy and Asthma Medical Group, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Los Angeles : California Allergy and Asthma Medical Group, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Los Angeles : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Los Angeles : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Los Angeles : Vectura Clinical Trial Site 10031
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Los Angeles : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Los Angeles :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Los Angeles : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Los Angeles : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Los Angeles : Axis Clinical Trials
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
Los Angeles : California Allergy and Asthma
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
Los Angeles : Investigational Site 909
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Los Angeles : Investigational Site 852
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Mission Viejo : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Mission Viejo : Allergy & Asthma Associates of Southern California
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Mission Viejo : Southern California Research
A Study of ARRY-502 in Patients With Persistent Asthma
Mission Viejo :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Mission Viejo :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Mission Viejo : Call for Information (Investigational Site 0105)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Mission Viejo : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Napa :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Newport Beach : Teva Investigational Site 10536
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Newport Beach : Teva Investigational Site 10136
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Newport Beach : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Newport Beach : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Newport Beach : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Newport Beach : Investigational Site 864
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Orange : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Orange : CHOC PSF, AMC, Division of Allergy, Asthma & Immunology
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Orange :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Orange :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Orange : Teva Investigational Site 10540
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Orange : Teva Investigational Site 10140
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Orange : Choc Pediatric Subspeciality Faculty
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Orange : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Orange : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Orange : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Palmdal : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Palmdale : Teva Investigational Site 10578
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Rancho Mirage :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Rancho Mirage : Investigational Site 812
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Redwood City :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Redwood City :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Redwood City : Teva Investigational Site 10185
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Riverside :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Riverside :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Riverside : Call for Information (Investigational Site 0125)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Riverside : Teva Investigational Site 10143
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Riverside : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Riverside : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Riverside : Integrated Research Group
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
Riverside : Investigational Site 808
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Rolling Hills Estates : Peninsula Research Associates
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Rolling Hills Estates : Peninsula Research Associates
A Study of ARRY-502 in Patients With Persistent Asthma
Rolling Hills Estates : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Rolling Hills Estates : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Roseville : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Roseville : Call for Information (Investigational Site 9043) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Sacramento : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Sacramento : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Sacramento :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Sacramento : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Sacramento :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Sacramento : Investigational Site 804
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
San Diego : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
San Diego : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
San Diego : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
San Diego : Allergy & Asthma Med Group/Research Center
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
San Diego : Allergy Associates Medical Group. Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
San Diego : Allergy Associates Medical Group
A Study of ARRY-502 in Patients With Persistent Asthma
San Diego :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
San Diego : Teva Investigational Site 10582
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
San Diego : Teva Investigational Site 10130
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Diego : Teva Investigational Site 10182
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Diego : Allergy & Asthma Medical Group & Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Diego : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
San Diego : University of Southern California, San Diego
Long-acting Beta Agonist Step Down Study
San Diego : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Francisco : Ovation Research Group
Impact of Asthma Treatments on Daily Activities
San Jose : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
San Jose : Call for Information (Investigational Site 0052) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
San Jose : Allergy & Asthma Associates of Santa Clara Valley
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
San Jose : Teva Investigational Site 10563
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
San Jose : Teva Investigational Site 10179
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Jose : Amphastar Site 1
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
San Jose : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Jose : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
San Jose :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
San Jose : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
San Mateo :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
San Mateo : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
San Mateo : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
South San Francisco : Genentech Trial Information Support Line
An Observational Study of the Use and Safety of Xolair During Pregnancy
Stockton : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Stockton : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Stockton : Bensch Research Associates
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Stockton :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Stockton : Call for Information (Investigational Site 0104)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Stockton : Teva Investigational Site 10506
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Stockton : Teva Investigational Site 10106
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Stockton : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Stockton : 205.456.01004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Studio City :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Torrance :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Vista : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Vista : Vectura Clinical Trial Site 10016
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Vista : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Walnut Creek :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Walnut Creek : Teva Investigational Site 10529
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Walnut Creek : Teva Investigational Site 10129
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Walnut Creek : Allergy & Asthma Clinical Research, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Walnut Creek : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Woodland : Woodland Medical Center
Effectiveness of the Asthmapolis Monitoring System
Colorado
Centennial : 1st International Clinical Research Center
Is your asthma uncontrolled?
Colorado MERCKngs : Research Site
A clinical research study for asthmatics 12 years and over.
Wheat Ridge : Research Site
A clinical research study for asthmatics 12 years and over.
Wheat Ridge : Western States Clinical Research, Inc.
Will you help us evaluate an investigational study medication for the treatment of moderate to severe Asthma?
View More »
Centennial : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Centennial : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Centennial : Colorado Allergy and Asthma Clinic, PC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Centennial : Colorado Allergy and Asthma Center
A Study of ARRY-502 in Patients With Persistent Asthma
Centennial : IMMUNOe International Research Centers
A Study of ARRY-502 in Patients With Persistent Asthma
Centennial :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Centennial :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Centennial :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Centennial : Teva Investigational Site 10545
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Centennial : Teva Investigational Site 10145
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Centennial : Vectura Clinical Trial Site 10023
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Centennial : Investigational Site 837
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Colorado Springs : Asthma & Allergy Associates, PC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Colorado Springs : Asthma & Allergy Associates PC
A Study of ARRY-502 in Patients With Persistent Asthma
Colorado Springs :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Colorado Springs :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Colorado Springs : Teva Investigational Site 10572
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Colorado Springs : Teva Investigational Site 10172
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Colorado Springs : Asthma And Allergy Associates, P.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Storms Clinical Research Institute
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Asthma & Allergy Associates, P.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Colorado Springs : Vectura Clinical Trial Site 10001
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Colorado Springs :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Denver : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Denver : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Denver : Colorado Allergy & Asthma Centers, PC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Denver : National Jewish Health
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Denver :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Denver : Teva Investigational Site 10154
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Denver : National Jewish Health
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Denver : National Jewish Medical and Research Center
Cell Biology of Steroid Resistant Asthma
Denver : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Denver :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Denver : 205.446.01011 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Denver : National Jewish Health
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Denver : National Jewish Health
Markers of Airway Inflammation in BAL Fluid From Children With Asthma
Denver : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Denver : Investigational Site 851
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Engelwood : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Englewood : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Lakewood : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Thornton : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Wheat Ridge : Rocky Mountain Center for Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Wheat Ridge :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Wheat Ridge : Teva Investigational Site 10128
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Wheat Ridge : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Wheat Ridge : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Wheat Ridge : Investigational Site 832
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Connecticut
Waterbury : Biomedical Research Alliance of New York
Asthma
View More »
New Haven :
A Non-drug Study Profiling Asthma
New Haven : Yale University Center for Asthma and Airway Disease
Bronchial Thermoplasty in Severe Persistent Asthma
Waterbury : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Waterbury :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Waterbury : Teva Investigational Site 10528
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Waterbury : Waterbury Pulmonary Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Waterbury :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Florida
Aventura : Florida Center for Allergy and Asthma Research
12 week dose ranging study to evaluate the efficacy and safety of Fluticasone Propionate Spiromax administered twice daily compared with placebo in adolescents and adults with persistent asthma uncontrolled on non-steroidal therapy
Aventura : Research Site
A clinical research study for asthmatics 12 years and over.
Bradenton : Research Site
A clinical research study for asthmatics 12 years and over.
Coral Gables : Research Site
A clinical research study for asthmatics 12 years and over.
Hialeah : Research Site
A clinical research study for asthmatics 12 years and over.
Kissimmee : Research Site
A clinical research study for asthmatics 12 years and over.
Miami : Florida Center for Allergy and Asthma Research
12 week dose ranging study to evaluate the efficacy and safety of Fluticasone Propionate Spiromax administered twice daily compared with placebo in adolescents and adults with persistent asthma uncontrolled on non-steroidal therapy
Miami : Research Site
A clinical research study for asthmatics 12 years and over.
Miami : Research Site
A clinical research study for asthmatics 12 years and over.
Miami : Research Site
A clinical research study for asthmatics 12 years and over.
Miami : Research Site
A clinical research study for asthmatics 12 years and over.
Ocala : Research Site
A clinical research study for asthmatics 12 years and over.
Panama City : Emerald Coast Research Associates
Research study for Asthma
Pinellas Park : Radiant Research - St. Petersburg
Clinical Research for Asthma
Pinellas Park : Radiant Research - St. Petersburg
Clinical Research Study for Asthma
Sarasota : Research Site
A clinical research study for asthmatics 12 years and over.
St. Petersburg : SCORE Physician Alliance
Do you, or does your child have asthma?
Tampa : Clinical Research of West Florida, Inc.
Do you have trouble controlling your asthma?
West Palm Beach : Palm Beach Research Center
Have you been diagnosed with Asthma that is sometimes difficult to control?
Winter Park : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Altamonte Springs : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Aventura : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Aventura : Florida Center for Allergy & Asthma Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Aventura : Teva Investigational Site 10537
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Aventura : Teva Investigational Site 10137
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Aventura : Teva Investigational Site 10153
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Aventura : Novartis Investigative Site
A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
Aventura : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Aventura : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Boyton Beach : Teva Investigational Site 10556
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Clearwater : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Clearwater : Teva Investigational Site 11507
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Clearwater : Saint Francis Sleep Allergy and Lung Institute
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Clearwater : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Clearwater : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Coral Gables : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Coral Gables : Call for Information (Investigational Site 0068) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Debary : Omega Research Consultants LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Gainesville : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Gainesville :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Hialeah : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Jacksonville : Clinical Neuroscience Solutions
A Study of ARRY-502 in Patients With Persistent Asthma
Jacksonville : Nemours Children's Clinic
Genotype Stratified Pharmacokinetic Study of Montelukast
Jacksonville : Nemours Children's Clinic
Long-acting Beta Agonist Step Down Study
Jacksonville : Investigational Site 855
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Jacksonville : Nemours Children's Clinic
Transporter Mediated Uptake of Montelukast
Kissimmee : Pulmonary Disease Specialists
A Study of ARRY-502 in Patients With Persistent Asthma
Kissimmee :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Largo : Innovative Research of West Florida
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lehigh Acres : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Melbourne : Accelovance
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Miami : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Miami : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Miami : Call for Information (Investigational Site 0044) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Miami : South Florida Research Trials
A Study of ARRY-502 in Patients With Persistent Asthma
Miami :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Miami : Teva Investigational Site 11508
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Miami : Teva Investigational Site 11514
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Miami : Community Research Foundation
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Kendall South Medical Center, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Florida Center for Allergy and Asthma Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Kendall South Medical Center, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miami : Pulmonary Human Research Laboratory, University of Miami, Miller School of Medicine
Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide
Miami : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Miami : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Miami : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Miami : Investigational Site 865
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Miami : Investigational Site 881
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
North Palm Beach :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Ocala :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Ocala : Teva Investigational Site 10571
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Ocala : Teva Investigational Site 10171
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Opalocka : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Orange City : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Orlando : GSK Investigational Site
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Ormond Beach : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Panama City :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Port Charlotte : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sarasota : Sarasota Clinical Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Sarasota : Teva Investigational Site 10178
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sarasota : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Sarasota : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
South Miami : Teva Investigational Site 10593
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
South Miami : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tallahassee : Allergy & Asthma Diagnostic Treatment Center
A Study of ARRY-502 in Patients With Persistent Asthma
Tallahassee :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Tallahassee : Teva Investigational Site 10161
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Tallahassee : Allergy And Asthma Dtc
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tallahassee : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Tampa :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Tampa : Teva Investigational Site 10139
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Tampa : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Tampa : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Trinity : Advanced Research Institute, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Valrico : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Winter Park : Florida Pulmonary Research Institute
A Study of ARRY-502 in Patients With Persistent Asthma
Winter Park :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Winter Park :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Georgia
Atlanta : Research Site
A clinical research study for asthmatics 12 years and over.
Atlanta : Radiant Research - Atlanta
Clinical Research for Asthma
Atlanta : Pinnacle Trials, Inc.
Do you have both Diabetes & Asthma?
Columbus : Southeast Regional Research Group - Columbus
Flute Clinical Study - Asthma
Columbus : Southeast Regional Research Group - Columbus
Trumpet Clinical Study - Asthma
Gainesville : Research Site
A clinical research study for asthmatics 12 years and over.
Lawrenceville : DataQuest Medical Research, LLC
Adult Asthma Study for African American Patients
Savannah : Research Site
A clinical research study for asthmatics 12 years and over.
Stockbridge : Clinical Research Atlanta
Do you, or does your child have asthma? The study is a clinical research study being conducted worldwide. The study is comparing a medication which is a combination of two differenct drugs (fluticasone propionate and salmeterol) to a medication that has only one drug (fluticasone propionate alone). Both the combination drug and fluticasone propionate alone are currently available by prescription outside this clinical research study.
View More »
Albany : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Albany : Georgia Pollens Clinical Research Centers, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Albany :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Albany :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Albany : Teva Investigational Site 11504
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Albany : Vectura Clinical Trial Site 10011
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Albany : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Albany : Investigational Site 805
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Columbus : Brookstone Centre Parkway
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Columbus :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Columbus : Teva Investigational Site 10511
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Columbus : Teva Investigational Site 11510
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Columbus : Teva Investigational Site 10111
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Columbus : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Duluth :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Gainesville : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Gainesville : Teva Investigational Site 10180
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Gainsville : Call for Information (Investigational Site 0130)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Lawrenceville : Teva Investigational Site 10168
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lawrenceville : DataQuest Medical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lawrenceville : DataQuest Medical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lawrenceville :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Lilburn : Allergy and Asthma Consultants PC Laboratory
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Savannah :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Savannah : Call for Information (Investigational Site 0109)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Savannah : Aeroallergy Research Labs Of Savannah, Inc
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Savannah : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Savannah : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Savannah :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Savannah : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Stockbridge : Investigational Site 870
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Woodstock :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Hawaii
Honolulu :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Idaho
Meridian : Research Site
A clinical research study for asthmatics 12 years and over.
Meridian : Advanced Clinical Research, ID
Do You Have Trouble Controlling Your Asthma?
Twin Falls : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Coeur D'Alene : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Couer D'Alene : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Eagle : Idaho Allergy DBA Idaho Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Eagle : Idaho Research
A Study of ARRY-502 in Patients With Persistent Asthma
Meridian : Teva Investigational Site 10116
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Twin Falls :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Twin Falls :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Illinois
Chicago : Research Site
A clinical research study for asthmatics 12 years and over.
Decatur : Research Site
A clinical research study for asthmatics 12 years and over.
DeKalb : Research Site
A clinical research study for asthmatics 12 years and over.
River Forest : Asthma and Allergy Center of Chicago, SC
Asthma Research for adult asthmatics using daily asthma medications (ICS)
River Forest : Asthma and Allergy Center of Chicago, SC
Research study for people with uncontrolled severe Asthma. If you are taking inhaled corticosteroids, need to use rescue several times a week and if you have been sick with asthma worsening more than two times during last year; you may be eligible to participate in our asthma study.
View More »
Chicago : University of Chicago
Bronchial Thermoplasty in Severe Persistent Asthma
Chicago : Cedar-Crosse Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Chicago : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Chicago : Investigational Site 816
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Hinsdale : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Normal : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Normal : Sneeze, Wheeze & Itch Associates
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Normal : Sneeze, Wheeze & Itch
A Study of ARRY-502 in Patients With Persistent Asthma
Normal :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Normal :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Normal : Call for Information (Investigational Site 0123)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Normal : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Normal : 205.456.01008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Normal : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Normal : Call for Information (Investigational Site 9048) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
River Forest :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
River Forest : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
River Forest : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Shiloh : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Shiloh : Investigational Site 824
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Skokie : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Springfield : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Indiana
Evansville : Research Site
A clinical research study for asthmatics 12 years and over.
South Bend : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Evansville : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Evansville : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Evansville : Investigational Site 883
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Fort Wayne : Investigational Site 878
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Indianapolis :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Indianapolis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Lafayette :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
South Bend : Teva Investigational Site 10527
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
South Bend : Teva Investigational Site 10127
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Iowa
Iowa City : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Iowa City :
A Non-drug Study Profiling Asthma
Iowa City : Iowa Clinical Research Corporation
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Iowa City : University of Iowa
Bronchial Thermoplasty in Severe Persistent Asthma
Iowa City : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Kansas
Lenexa : Research Site
A clinical research study for asthmatics 12 years and over.
Overland Park : Radiant Research - Kansas City
Clinical Research for Asthma
Topeka : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Lenexa : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Lenexa : Investigational Site 820
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Overland Park : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Overland Park :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Overland Park :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Overland Park : Teva Investigational Site 11501
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Topeka :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Topeka : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Kentucky
Lexington : University of Kentucky Chandler Medical Center
Assessment of Breathing in Individuals With Vocal Cord Dysfunction
Lexington : Central Kentucky Research Associates
Asthma
Lexington : University of Kentucky Chandler Medical Center
Asthma Volunteers Needed for Research Study
Lexington : University of Kentucky Chandler Medical Center
Have You Been Diagnosed With Asthma?
Owensboro : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Lexington : University of Kentucky
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Louisville :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Louisville : Family Allergy and Asthma Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lousiville : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Nicholasville : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Owensboro : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Owensboro : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Owensboro : Investigational Site 873
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Louisiana
Sunset : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Lafayette : Investigational Site 801
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Mandeville : Investigational Site 877
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Marrero : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Metairie :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Metairie : Teva Investigational Site 10113
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Metairie : Clinical Research Specialists
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Metairie : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Metairie : Vectura Clinical Trial Site 10002
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Metairie : Call for Information (Investigational Site 9033) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Metarie : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Orleans : LSU Health Sciences
Bronchial Thermoplasty in Severe Persistent Asthma
Shreveport : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Sunset : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Maine
Bangor :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Bangor : Teva Investigational Site 10564
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Bangor : Teva Investigational Site 10164
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bangor : Paul Shapero's Private Practice
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bangor : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
Bangor : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Maryland
Baltimore : Research Site
A clinical research study for asthmatics 12 years and over.
Salisbury : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Baltimore : Johns Hopkins Asthma and Allergy Center
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
Baltimore : Chesapeake Clinical Research, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Baltimore : Chesapeake Clinical Research Inc
A Study of ARRY-502 in Patients With Persistent Asthma
Baltimore :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Baltimore :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Baltimore : Johns Hopkins Asthma and Allergy Center
Effect of Anti-IgE in Non-Allergic Asthma
Baltimore : 205.456.01003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Baltimore : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bethesda : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Bethesda : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bethesda : NIH Clinical Center
A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
Bethesda : Teva Investigational Site 10158
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bethesda : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Bethesda : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Lanham : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Largo : Teva Investigational Site 10110
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Wheaton : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Wheaton : Call for Information (Investigational Site 0072) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Wheaton : Teva Investigational Site 10577
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Wheaton : Teva Investigational Site 10177
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Wheaton : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
White Marsh : Call for Information (Investigational Site 0069) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
White Marsh : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
White Marsh : Investigational Site 875
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Massachusetts
Brockton : Research Site
A clinical research study for asthmatics 12 years and over.
North Dartmouth : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Boston : Brigham and Women's Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Boston : St. Elizabeth's Medical Center
Bronchial Thermoplasty in Severe Persistent Asthma
Brockton :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Burlington : Lahey Clinic
Bronchial Thermoplasty in Severe Persistent Asthma
Fall River : Investigational Site 871
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
North Dartmouth : Northeast Medical Research Associates, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
North Dartmouth : Northeast Medical Research Associates
A Study of ARRY-502 in Patients With Persistent Asthma
North Dartmouth : Teva Investigational Site 10546
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
North Dartmouth : Teva Investigational Site 10146
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
North Dartmouth : Teva Investigational Site 10138
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
North Dartmouth : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
North Dartmouth : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
North Dartmouth : 205.446.01003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
North Dartmouth : Teva Investigational Site 10236
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma
North Dartmouth : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
North Dartmouth : Investigational Site 834
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Michigan
Ann Arbor : ClinSite, LLC
Diagnosed with Asthma?
Minneapolis : Research Site
A clinical research study for asthmatics 12 years and over.
St Clair Shores : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Ann Arbor : University of Michigan
Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity
Bay City :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Canton : Hamzavi Dermatology/Dermatology Specialists of Canton
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Detroit : Henry Ford Hospital
Bronchial Thermoplasty in Severe Persistent Asthma
Fort Gratiot : Hamzavi Dermatology
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Grand Blanc : Grand Blanc Medical
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Grand Rapids : Spectrum Health Hospitals
Bronchial Thermoplasty in Severe Persistent Asthma
Kalamazoo : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Novi :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Southfield : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Troy : Teva Investigational Site 11502
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Troy : Investigational Site 889
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Ypsilanti : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Ypsilanti : Respiratory Medicine Researh Institute of Michigan
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Ypsilanti :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Minnesota
Chaska : Ridgeview Research
Asthma
Minneapolis : Clinical Research Institute, MN
731/732 Asthma Research Study for Adolescents and Adults
Minneapolis : Clinical Research Institute, MN
738/739 Adult Asthma Research Study
Minneapolis : Clinical Research Institute, MN
742_743 Adult Asthma Research Study
Minneapolis : Clinical Research Institute, MN
ADOLESCENT ASTHMA RESEARCH STUDY_678
Minneapolis : Clinical Research Institute, MN
Adult Asthma Research Study_707
Minneapolis : Clinical Research Institute, MN
Asthma Research Study for Adolescents & Adults_712
Plymouth : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Edina : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Minneapolis : Clinical Research Institute
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Minneapolis : Clinical Research Institute
A Study of ARRY-502 in Patients With Persistent Asthma
Minneapolis :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Minneapolis : Teva Investigational Site 10131
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Minneapolis : Clinical Research Institute
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Minneapolis : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Minneapolis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Plymouth : Clinical Research Institute, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Plymouth : Clinical Research Institute
A Study of ARRY-502 in Patients With Persistent Asthma
Plymouth :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Plymouth : Teva Investigational Site 10531
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Plymouth : Vectura Clinical Trial Site 10008
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Plymouth : 205.444.01004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Plymouth : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
St. Paul : HealthPartners Specialty Center, Lung and Sleep Health
Bronchial Thermoplasty in Severe Persistent Asthma
Mississippi
Vicksburg : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Missouri
Creve Couer : The Clinical Research Center, LLC
Have you been using a maintenance inhaler to treat your asthma for the last 6 months? If so you may qualify for an asthma research study.
Rolla : Research Site
A clinical research study for asthmatics 12 years and over.
St. Louis : Research Site
A clinical research study for asthmatics 12 years and over.
St. Louis : Research Site
A clinical research study for asthmatics 12 years and over.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
A Washington University asthma study seeks volunteers 12 - 75 years of age.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
A Washington University asthma study seeks volunteers that take Advair, Dulera or Symbicort for their asthma.
St. Louis : Washington University
Are you taking Xolair?
St. Louis : Midwest Clinical Research LLC
Asthma Clinical Trial
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Asthma patients! Do you use controller medications to treat your asthma?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Asthma Study Seeks Volunteers!
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Asthmatics! Washington University seeks asthmatics for a research study using an add-on treatment study medication.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Asthmatics! Washington University seeks participants for a research study on severe asthma.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Attention Female Asthmatics! Washington University seeks female asthmatics for a research study looking at the effects of an asthma medication!
St. Louis : Radiant Research - St. Louis
Clinical Research Study for Asthma
St. Louis : The Clinical Research Center, LLC
Do you continue to experience asthma symptoms despite treatment with medication? We are seeking asthmatics who are currently on high-dose inhaled corticosteriods to participate in an clinical trial for asthma.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have a runny, stuffy nose or sinus infection or inflammation?
St. Louis : The Clinical Research Center, LLC
Do you have asthma and allergies have been treated with prednisone in the last 18 months? If so you may qualify for an asthma study.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have asthma?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have asthma? Are you interested in taking Vitamin D?
St. Louis : The Clinical Research Center, LLC
Do you use a rescue inhaler on a weekly basis to treat your asthma? If so you may qualify for an asthma research study.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Do you use daily inhaled corticosteroids?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Healthy Participants and Participants with severe asthma are needed for a research study at Washington University.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Is Your Asthma Well Controlled? Are You Taking Dulera, Symbicort, or Advair for Your Asthma?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Participants with mild asthma are needed for a research study at Washington University.
View More »
Chesterfield :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Columbia : Clinical Research of The Ozarks, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Columbia : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Columbia : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Columbia : 205.456.01007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Columbia : 205.445.01002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Columbia : 205.446.01009 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Columbia : 205.444.01005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Columbia : 205.443.12003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Kansas City : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Kansas City :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Kansas City : University of Missouri, Kansas City School of Medicine
Long-acting Beta Agonist Step Down Study
Kansas City : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Ozark : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rolla : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Rolla : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rolla : Investigational Site 838
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Saint Louis :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Saint Louis :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
St Louis : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
St Louis : The Clinical Research Center, LLC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
St Louis :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
St Louis :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
St Louis : Teva Investigational Site 10589
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
St. Louis : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
St. Louis :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
St. Louis : Teva Investigational Site 10575
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
St. Louis : Teva Investigational Site 10175
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
St. Louis : Washington University School of Medicine
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Louis : The Clinical Research Center, L.L.C.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
St. Louis : Washington University School of Medicine
Bronchial Thermoplasty in Severe Persistent Asthma
St. Louis : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
St. Louis : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
St. Louis : Washington University/St. Louis University
Long-acting Beta Agonist Step Down Study
St. Louis : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
St. Louis : Investigational Site 818
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
St. Louis : Investigational Site 841
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Warrensburg : Call for Information (Investigational Site 0118)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Warrensburg : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Warrensburg : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Montana
Billings : Research Site
A clinical research study for asthmatics 12 years and over.
Missoula : Research Site
A clinical research study for asthmatics 12 years and over.
Missoula : Montana Medical Research, Inc.
Have you been diagnosed with Asthma?
View More »
Billings : Billings Clinic Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Boseman : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bozeman : Clinical Research Group of Montana PLLC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Bozeman : Clinical Research Group of Montana
A Study of ARRY-502 in Patients With Persistent Asthma
Missoula :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Missoula : Vectura Clinical Trial Site 10009
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Nebraska
Bellevue : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Bellevue : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bellevue : The Asthma & Allergy Center
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Bellevue : The Asthma & Allergy Center
A Study of ARRY-502 in Patients With Persistent Asthma
Bellevue :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
View More »
Bellevue :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Bellevue : Teva Investigational Site 10518
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Bellevue : Teva Investigational Site 10118
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Bellevue : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Boys Town : Boys Town National Research Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Grand Island : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Omaha : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Omaha : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Omaha :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Omaha :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Omaha : Teva Investigational Site 10550
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Omaha : Teva Investigational Site 10150
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Omaha : Midwest Allergy and Asthma Clinic
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Omaha : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Omaha : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Papillion : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Papillon : The Asthma And Allergy Center, Pc
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Papillon : The Asthma And Allergy Center, Pc
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nevada
Las Vegas : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Las Vegas :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Las Vegas : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Reno :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
New Jersey
Berlin : Research Site
A clinical research study for asthmatics 12 years and over.
Edison : Anderson & Collins Clinical Research, Inc.
Asthma Research Study
View More »
Berkely Heights : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Brick :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Brick : Teva Investigational Site 10114
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Brick : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Brick : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Cedar Knolls : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Cherry Hill : Teva Investigational Site 10559
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Edison :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Edison :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Hillsborough : Teva Investigational Site 10501
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Hillsborough : Teva Investigational Site 10101
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Ocean : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Ocean : Atlantic Research Center, LLC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Ocean :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Skillman : Princeton Center for Clinical Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Skillman : Princeton Center for Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Skillman : Teva Investigational Site 10155
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Skillman : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Skillman : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Skillman : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Summit :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Teaneck :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Teaneck : Call for Information (Investigational Site 9049) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Verona : Allergy Consultants, PA
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Verona :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
West Orange : Teva Investigational Site 10188
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
New Mexico
Albuquerque :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Albuquerque : Teva Investigational Site 11503
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Albuquerque : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Albuquerque : Investigational Site 857
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
New York
Bronx : Biomedical Research Alliance of New York
Asthma
Bronx : Biomedical Research Alliance of New York
Asthma
Bronx : Biomedical Research Alliance of New York
Asthma
Brooklyn : Research Site
A clinical research study for asthmatics 12 years and over.
Mineola : Winthrop University Hospital Clinical Trials Center
Asthma Study - Are You Taking Xolair
New Hyde Park : Biomedical Research Alliance of New York, LLC
Symbicort treatment for patients with asthma
New York : Biomedical Research Alliance of New York, LLC
Symbicort treatment for patients with asthma
Newburgh : Research Site
A clinical research study for asthmatics 12 years and over.
North Syracuse : Research Site
A clinical research study for asthmatics 12 years and over.
Rochester : AAIR Research Center
Attention Those With Asthma: We Understand the Difficulties of Living with Asthma.
Rochester : AAIR Research Center
Does Your Child Suffer From Asthma? The triggers for asthma are all around us-colds, pets, pollen, pollution and even the weather.
Rochester : AAIR Research Center
Losing Control of Asthma Can Keep People From Doing the Things They Enjoy.
Rochester : AAIR Research Center
Seeking Volunteers with Asthma for an Investigational New Research Study
View More »
Bronx :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Bronx : Teva Investigational Site 10580
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Bronx : Bronx Medical Center for Pulmonary, Asthma and Sleep Disorde
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Corning : Call for Information (Investigational Site 0070) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Endwell : Call for Information (Investigational Site 0043) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Great Neck : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Great Neck :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Great Neck : North Shore-Long Island Jewish Health System, Division of Allergy/Immunology
The Effect of Montelukast on Asthma Control in Obese Asthmatic Children and Adolescents
Mineola : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
New Hyde Park : North Shore Diabetes and Endocrine Associates
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New Hyde Park : Hofstra North Shore-LIJ School of Medicine
Long-acting Beta Agonist Step Down Study
New York : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
New York : New York Pulmonary Associates, P.C.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
New York :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
New York : Teva Investigational Site 10520
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
New York : Teva Investigational Site 10120
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
New York : MedHex Health
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : New York University School of Medicine
Long-acting Beta Agonist Step Down Study
New York : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Newburgh : Teva Investigational Site 10532
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Newburgh : Teva Investigational Site 10190
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Newburgh : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Newburgh : Investigational Site 819
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
North Syracuse :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
North Syracuse : Teva Investigational Site 10567
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
North Syracuse : Teva Investigational Site 10167
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rochester : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Rochester : Allergy Asthma Immunology of Rochester (AAIR)
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Rochester : Call for Information (Investigational Site 0115)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Rochester : Teva Investigational Site 10512
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Rochester : Teva Investigational Site 10112
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rochester : AAIR Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rochester : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rockville Centre : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Rockville Centre :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Rockville Centre : 205.456.01001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Utica : St. Elizabeth Health Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Valhalla : Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College
Long-acting Beta Agonist Step Down Study
North Carolina
Cary : PMG Research of Cary
Do you have Asthma?
Charlotte : American Health Research
16 week study for Patients with Asthma
Charlotte : American Health Research
16 week Study for Patients with Asthma being treated with Advair, Flovent or Equivalent
Charlotte : American Health Research
26 week study Comparing Advair to Flovent in Patients with Asthma
Greensboro : Research Site
A clinical research study for asthmatics 12 years and over.
High Point : Research Site
A clinical research study for asthmatics 12 years and over.
Wilmington : PMG Research of Wilmington
Do you have Asthma?
Winston-Salem : PMG Research of Winston-Salem
Do you have Asthma?
View More »
Charlotte : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Charlotte : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Charlotte : Teva Investigational Site 10244
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma
Charlotte : Investigational Site 844
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Durham : Duke University
Bronchial Thermoplasty in Severe Persistent Asthma
Greensboro : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
High Point : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
High Point : Peters Medical Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
High Point :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
High Point : Call for Information (Investigational Site 0103)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
High Point : Teva Investigational Site 10105
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
High Point : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Raleigh : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Raleigh : North Carolina Clinical Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Raleigh : North Carolina Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Raleigh : Call for Information (Investigational Site 0117)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Raleigh : Teva Investigational Site 10122
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Raleigh : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Raleigh : Novartis Investigative site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Shelby : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Willimgton :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Winston-salem : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Winston-Salem : Wake Forest University Health Sciences
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Winston-Salem : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
North Dakota
Fargo : Lillestol Research LLC
A Study of ARRY-502 in Patients With Persistent Asthma
Ohio
Akron : Research Site
A clinical research study for asthmatics 12 years and over.
Akron : Radiant Research - Akron
Clinical Research for Asthma
Canton : Research Site
A clinical research study for asthmatics 12 years and over.
Carlisle : Research Site
A clinical research study for asthmatics 12 years and over.
Cleveland : Rapid Medical Research, Inc. (RMR)
Do You Have Trouble Controlling Your Asthma?
Columbus : Research Site
A clinical research study for asthmatics 12 years and over.
Dayton : Research Site
A clinical research study for asthmatics 12 years and over.
Sylvania : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Canton : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Canton : Allergy, Respiratory & Sleep Center
A Study of ARRY-502 in Patients With Persistent Asthma
Canton :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Canton : Teva Investigational Site 10522
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Canton : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Canton : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Canton : Call for Information (Investigational Site 9037) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Centerville :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Cincinnati : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Cincinnati : Call for Information (Investigational Site 0042) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Cincinnati : Call for Information (Investigational Site 0053) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Cincinnati : New Horizons Clinical Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Cincinnati : Bernstein Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Cincinnati :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Cincinnati :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Cincinnati :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Cincinnati : Call for Information (Investigational Site 0106)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Cincinnati : Teva Investigational Site 10507
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Cincinnati : Teva Investigational Site 10523
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Cincinnati : Teva Investigational Site 10107
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Cincinnati : Teva Investigational Site 10123
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Cincinnati : New Horizons Clinical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Cincinnati : Bernstein Clinical Research Center, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Cincinnati : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Cincinnati : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Cincinnati : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Cincinnati : 205.456.01005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Cincinnati : 205.445.01001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Cincinnati : 205.446.01005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Cincinnati : 205.444.01001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Cincinnati : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Cleveland :
A Non-drug Study Profiling Asthma
Cleveland : MetroHealth Medical Center
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
Cleveland : Cleveland Clinic Foundation
Bronchial Thermoplasty in Severe Persistent Asthma
Cleveland : The Cleveland Clinic
Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing
Columbus : Teva Investigational Site 10144
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Columbus : Optimed Research, LTD
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Columbus : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Columbus : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Dayton : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Marion : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Middleburg Heights : Teva Investigational Site 11505
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Middleburg Heights : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Middleburg Heights : Investigational Site 845
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Stow : Call for Information (Investigational Site 0067) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Sylvania : Toledo Center for Clinical Research
A Study of ARRY-502 in Patients With Persistent Asthma
Sylvania : Vectura Clinical Trial Site 10010
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Sylvania : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Toledo : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Toledo :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Oklahoma
Oklahoma City : Research Site
A clinical research study for asthmatics 12 years and over.
Tulsa : Vital Prospects Clinical Research Institute, P.C.
Asthma
Tulsa : Vital Prospects Clinical Research Institute, P.C.
Uncontrolled Asthma
View More »
Norman : Ekips Technologies, Inc.
Development of a Breath Analyzer for Asthma Screening
Oklahoma :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Oklahoma City : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Oklahoma City : Allergy, Asthma & Clinical Research Center
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Oklahoma City : IPS Research Company
A Study of ARRY-502 in Patients With Persistent Asthma
Oklahoma City : Allergy Asthma & Clinical Research Center
A Study of ARRY-502 in Patients With Persistent Asthma
Oklahoma City :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Oklahoma City : Teva Investigational Site 10560
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Oklahoma City : Teva Investigational Site 10574
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Oklahoma City : Teva Investigational Site 10579
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Oklahoma City : Teva Investigational Site 10160
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Oklahoma City : Teva Investigational Site 10174
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Oklahoma City : Allergy, Asthma & Clinical Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Oklahoma City : Vectura Clinical Trial Site 10017
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Oklahoma City : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Oklahoma City :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Oklahoma City : 205.445.01010 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Oklahoma City : 205.446.01010 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Oklahoma City : 205.444.01014 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Oklahoma City : 205.443.12005 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Oklahoma City : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Oklahoma City : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tulsa : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Tulsa : Vital Prospects Clinical Research Institute, PC
A Study of ARRY-502 in Patients With Persistent Asthma
Tulsa :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Tulsa :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Tulsa : Investigational Site 810
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Oregon
Eugene : Clinical Trials of America, Inc
Do you, or does your child (12 years or older), have asthma?
Medford : Research Site
A clinical research study for asthmatics 12 years and over.
Portland : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Ashland : Teva Investigational Site 10598
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Ashland : Investigational Site 859
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Eugene : Allergy & Asthma Research Group
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Eugene :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Eugene : Teva Investigational Site 10132
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Gresham : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Lake Oswego : Baker Allergy, Asthma & Dermatology Research Center
A Study of ARRY-502 in Patients With Persistent Asthma
Lake Oswego :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Lake Oswego : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Medford : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Medford : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Medford : Clinical Research Inst. of Southern Oregon, PC
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Medford : Clinical Research Institute of Southern Oregon
A Study of ARRY-502 in Patients With Persistent Asthma
Medford :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Medford :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Medford : Teva Investigational Site 10135
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Medford : Clinical Research Institute of Southern Oregon, PC
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Medford : Amphastar Site 2
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
Medford : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Medford : Vectura Clinical Trial Site 10028
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Medford : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Medford : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Medford : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Medford : The Clinical Research Institute of Southern Oregn, PC
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Portland : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Portland : Call for Information (Investigational Site 0061) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Portland : Allergy Associates Research Center
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Portland :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Portland : Teva Investigational Site 10142
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Portland : Vectura Clinical Trial Site 10024
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Portland : 205.445.01005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Portland : Transitional Clinical Research, Inc. Allergy Associates Research Center
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Portland : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Portland : Investigational Site 859
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Pennsylvania
Bethlehem : Research Site
A clinical research study for asthmatics 12 years and over.
Blue Bell : Allergy & Asthma Specialists, P.C.
Currently enrolling asthmatics that are not well controlled on current asthma therapy.
Levittown : Research Site
A clinical research study for asthmatics 12 years and over.
Philadelphia : Research Site
A clinical research study for asthmatics 12 years and over.
Phoenixville : Research Site
A clinical research study for asthmatics 12 years and over.
Upland : Research Site
A clinical research study for asthmatics 12 years and over.
Wyomissing : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Altoona :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Altoona : Teva Investigational Site 10509
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Altoona : Central PA Asthma and Allergy Care, LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Blue Bell :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Blue Bell : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
Blue Bell : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Collegeville : Call for Information (Investigational Site 9035) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Easton :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Erie : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Feasterville : Call for Information (Investigational Site 0065) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Harrisburg :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Hershey : Pennsylvania State Hershey
Bronchial Thermoplasty in Severe Persistent Asthma
Jenkintown : Investigational Site 854
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Philadelphia :
A Non-drug Study Profiling Asthma
Philadelphia :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Philadelphia :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Philadelphia : Teva Investigational Site 10555
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Philadelphia : Teva Investigational Site 10183
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Philadelphia : University of Pennsylvania
Bronchial Thermoplasty in Severe Persistent Asthma
Philadelphia : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Pittsburgh : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Pittsburgh : Allergy & Clinical Immunology Associates
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Pittsburgh : University of Pittsburgh Asthma Institute
A Study of ARRY-502 in Patients With Persistent Asthma
Pittsburgh :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Pittsburgh : Teva Investigational Site 10566
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Pittsburgh : Teva Investigational Site 10166
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Pittsburgh : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Pittsburgh : Research Site
Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects
Pittsburgh : University of Pittsburgh
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
Pittsburgh : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Sellersville :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Upland : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Upland :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Upland : Teva Investigational Site 10521
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Upland : Teva Investigational Site 10121
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Upland : Vectura Clinical Trial Site 10021
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Rhode Island
East Providence : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Lincoln :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Lincoln :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Lincoln : Teva Investigational Site 10581
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Lincoln : Teva Investigational Site 10181
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Lincoln : Asthma & Allergy Physicians of Rhode Island Clinical Researc
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Lincoln : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Lincoln : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Providence :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Providence : Teva Investigational Site 10562
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Providence : Teva Investigational Site 10162
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Providence : Asthma, Nasal Disease & Allergy Research Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Providence : Investigational Site 843
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Warwick :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Warwick : Call for Information (Investigational Site 9053) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
South Carolina
Charleston : Research Site
A clinical research study for asthmatics 12 years and over.
Easly : Research Site
A clinical research study for asthmatics 12 years and over.
Greer : Radiant Research - Greer
Asthma Research Study
View More »
Charleston : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Charleston : National Allergy, Asthma and Uticaria Center of Charleston
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Charleston : National Allergy, Asthma, and Uticaria Centers
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Charleston : Teva Investigational Site 10526
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Charleston : Teva Investigational Site 10126
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charleston : Teva Investigational Site 10149
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charleston : Asthma & Allergy Consultants, LLP
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Charleston : Medical University of South Carolina
Bronchial Thermoplasty in Severe Persistent Asthma
Charleston : Vectura Clinical Trial Site 10003
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Charleston : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Charleston : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Charleston :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Charleston : 205.445.01006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Charleston : 205.446.01002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Charleston : 205.446.01004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Charleston : 205.444.01012 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Charleston : 205.444.01002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Columbia :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Florence : Investigational Site 802
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Fort Mill : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Fort Mill : Piedmont Research Partners LLC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Fort Mill : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Greenville : Greenville Pharmaceutical research, Inc.
12-Week Study in Adult Subjects With Asthma
Greenville : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Greenville :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Greenville :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Greenville : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Greenville :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Mt. Pleasant : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Orangeburg : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Orangeburg : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Orangeburg : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Orangeburg : Investigational Site 814
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Rock Hill : CU Pharmaceutical Research
A 12-Week Study in Adult Subjects With Asthma
Spartanburg :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Spartanburg : Teva Investigational Site 11515
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Spartanburg : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Spartanburg : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Spartanburg : Teva Investigational Site 10228
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma
Spartanburg : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Spartanburg : Investigational Site 821
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Spartanburg : Investigational Site 829
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Summerville : 205.456.01006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Summerville : 205.443.12004 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Tennessee
Bristol : PMG Research of Bristol
Do you have Asthma?
View More »
Bristol : Call for Information (Investigational Site 0066) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Chattanooga : Call for Information (Investigational Site 0049) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Kingsport : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Knoxville :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Knoxville : Investigational Site 850
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Nashville : Vanderbilt University Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nashville : Investigational Site 803
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Texas
Dallas : DallasAllergyImmunology Research
A 12 Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophillic Asthma
Dallas : DallasAllergyImmunology Research
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Dallas : DallasAllergyImmunology Research
A 6-month safety and benefit study of inhaled fluticasone propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with persistent asthma
Dallas : Research Site
A clinical research study for asthmatics 12 years and over.
Dallas : Research Site
A clinical research study for asthmatics 12 years and over.
Dallas : DallasAllergyImmunology Research
A dose-ranging study of fluticasone furoate (FF) inhalation powder in children aged 5-11 years with asthma.
Dallas : DallasAllergyImmunology Research
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Dallas : DallasAllergyImmunology Research
A Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.
Dallas : Radiant Research - Dallas, North
Asthma Research Study
Dallas : ACRC TRIALS
Asthma?
Dallas : Radiant Research - Dallas, North
Clinical Research for Asthma
Dallas : Pharmaceutical Research & Consulting, Inc.
Do you have asthma?
El Paso : Research Site
A clinical research study for asthmatics 12 years and over.
El Paso : Research Site
A clinical research study for asthmatics 12 years and over.
El Paso : Research Site
A clinical research study for asthmatics 12 years and over.
Fort Worth : Research Site
A clinical research study for asthmatics 12 years and over.
San Antonio : Research Site
A clinical research study for asthmatics 12 years and over.
San Antonio : Research Site
A clinical research study for asthmatics 12 years and over.
San Antonio : Radiant Research - San Antonio
Clinical Research Study for Asthma
San Antonio : Lung Diagnostics
Clinical research study for patients with Moderate-Severe Asthma
Waco : Allergy Asthma Research Institute
Adult Asthma Study
Waco : Allergy Asthma Research Institute
Do you suffer from Asthma?
Waco : Allergy Asthma Research Institute
Infants and toddlers with asthma symptoms (coughing, wheezing, shortness of breath).
Waco : Allergy Asthma Research Institute
Pediatric Asthma Study
View More »
Arlington :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Arlington :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Austin : Tekton Research
A Study of ARRY-502 in Patients With Persistent Asthma
Austin :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Austin : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Boerne : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Boerne : Hill Country Family Medical Center
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Boerne :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Boerne : Call for Information (Investigational Site 0110)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Boerne : Teva Investigational Site 10519
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Boerne : Teva Investigational Site 10119
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Boerne : Allergy and Asthma Center of Boerne
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Corsicana : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Dallas : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Dallas : Pharmaceutical Research & Consulting, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Dallas : Allergy/Immunology Research Center of North Texas
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Dallas : Pharmaceutical Research & Consulting Inc.
A Study of ARRY-502 in Patients With Persistent Asthma
Dallas :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Dallas : Call for Information (Investigational Site 0129)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Dallas : Teva Investigational Site 10542
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Dallas : Teva Investigational Site 10141
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Dallas : Allergy/Immunology Research Center of North Texas
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Dallas : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Dallas : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Dallas : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Dallas : Investigational Site 880
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Dickinson : Call for Information (Investigational Site 0039) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Dickinson : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Dickinson : Investigational Site 858
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
El Paso : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
El Paso : Western Sky Medical Research, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
El Paso : Western Sky Medical Research Inc
A Study of ARRY-502 in Patients With Persistent Asthma
El Paso :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
El Paso :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
El Paso :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
El Paso : Teva Investigational Site 10548
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
El Paso : Teva Investigational Site 10148
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
El Paso : Western Sky Medical Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
El Paso : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
El Paso : Western Sky Medical Research
Comparing Bronchodilation of Symbicort With and With Out Valved Holding Chamber (Aerochamber Plus)
El Paso : 205.445.01004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
El Paso : 205.444.01013 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
El Paso : Western Sky Medical
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
El Paso : Allergy and Asthma Center of El Paso
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
El Paso : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Fort Worth : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Fort Worth :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Fort Worth : North Texas Institute for Clinical Trials
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Fort Worth : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Fort Worth : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Forth Worth : Call for Information (Investigational Site 0119)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Forth Worth : Teva Investigational Site 11512
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Galveston : William Calhoun, MD
Bronchial Thermoplasty in Severe Persistent Asthma
Georgetown : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Houston : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Houston : Call for Information (Investigational Site 0056) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Houston : Call for Information (Investigational Site 0057) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Houston :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Houston : Pioneer Research Solutions, Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Houston : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Houston : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Live Oak : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Live Oak : Live Oak Allergy & Asthma Clinic
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Live Oak : Investigational Site 869
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
McKinney : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
McKinney :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
New Braunfels : Central Texas Health Research
A Study of ARRY-502 in Patients With Persistent Asthma
New Braunfels : Amphastar Site 3
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
New Braunfels : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Plano : Investigational Site 879
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
San Antonio : Teva Clinical Study Site
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
San Antonio : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
San Antonio : Call for Information (Investigational Site 9180) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
San Antonio : Sylvana Research Associates
A Study of ARRY-502 in Patients With Persistent Asthma
San Antonio :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
San Antonio :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
San Antonio : Call for Information (Investigational Site 0108)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
San Antonio : Call for Information (Investigational Site 0113)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
San Antonio : Teva Investigational Site 10569
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
San Antonio : Teva Investigational Site 10515
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
San Antonio : Teva Investigational Site 10115
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
San Antonio : Alamo Clinical Research Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Southwest Allergy and Asthma Research Center, P. A.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Alamo Clinical Research Associates
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
San Antonio : Amphastar Site 4
Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
San Antonio : Allergy & Asthma Center, PA
CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma
San Antonio : SAM Clinical Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
San Antonio : Sylvana Research Assocaites
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
San Antonio : Investigational Site
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing
San Antonio : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Spring : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Sugar Land :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Sugarland : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Sugarland :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Waco : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Waco : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Waco : Call for Information (Investigational Site 0038) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Waco : Allergy & Asthma Care of Waco, PA
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Waco : Allergy Asthma Research Institute
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Waco :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Waco : Call for Information (Investigational Site 0101)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Waco : Teva Investigational Site 10103
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Waco : GSK Investigational Site
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.
Waco : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Waco : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Waco : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Utah
Bountiful : Research Site
A clinical research study for asthmatics 12 years and over.
Draper : Research Site
A clinical research study for asthmatics 12 years and over.
Salt Lake City : Research Site
A clinical research study for asthmatics 12 years and over.
Salt Lake City : Optimum Clinical Research, Inc.
Asthma. Prevention of asthma related complications.
West Jordan : Advanced Clinical Research, UT
Do You Have Trouble Controlling Your Asthma?
West Jordan : Advanced Clinical Research, UT
Have You Been Diagnosed With Asthma?
View More »
Draper : Vectura Clinical Trial Site 10004
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Midvale : Call for Information (Investigational Site 0054) Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Murray :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Murray : Call for Information (Investigational Site 9050) Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Provo : Teva Investigational Site 10576
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Salt Lake City : Investigational Site 847
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
West Jordan : Investigational Site 876
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Vermont
Colchester : University of Vermont
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
South Burlington : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
South Burlington : Teva Investigational Site 10534
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
South Burlington : Teva Investigational Site 10134
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
South Burlington : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
South Burlington : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
South Burlington : 205.444.01003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
South Burlington : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Virginia
Midlothian : Virginia Research Center
Adolescent and Adult Subjects With Asthma
Newport News : Research Site
A clinical research study for asthmatics 12 years and over.
Newport News : Health Research of Hampton Roads, Inc.
Asthma Research
Richmond : Research Site
A clinical research study for asthmatics 12 years and over.
Richmond : Virginia Research Center
Adolescent and Adult Subjects With Asthma
Richmond : Pulmonary Associates of Richmond, Inc.
Asthma takes the air out of your game.
View More »
Abingdon : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Burke : Teva Investigational Site 10159
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Charlottesville : University of Virginia Medical Center
Bronchial Thermoplasty in Severe Persistent Asthma
Charlottesville : University of Virginia
Long-acting Beta Agonist Step Down Study
Fairfax : Teva Investigational Site 10502
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Fairfax : Investigational Site 840
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Manassas : Teva Investigational Site 10595
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Richmond : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Richmond :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Richmond : Call for Information (Investigational Site 0107)
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Richmond : Teva Investigational Site 10508
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Richmond : Teva Investigational Site 10108
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Richmond : Virginia Commonhealth University Health System
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Richmond : Pulmonary Associates of Richmond
Bronchial Thermoplasty in Severe Persistent Asthma
Richmond : Investigational Site 836
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Springfield :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Springfield :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Virginia Beach : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Washington
Vancouver : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Kirkland : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seattle : ASTHMA, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Seattle : Asthma Inc.
A Study of ARRY-502 in Patients With Persistent Asthma
Seattle :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Seattle : ASTHMA, Inc. Clinical Research Center
Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
Seattle : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seattle : Investigational Site 867
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Spokane :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Spokane :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Spokane : Teva Investigational Site 10524
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Spokane : Teva Investigational Site 10124
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Spokane : Investigational Site 833
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Tacoma : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Tacoma : MultiCare Pulmonary Specialists
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Tacoma : Teva Investigational Site 11511
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Tacoma : Teva Investigational Site 10530
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Tacoma : MultiCare Pulmonary Specialists
Bronchial Thermoplasty in Severe Persistent Asthma
Tacoma : Franciscan Research Center (St. Joseph Medical Center)
Bronchial Thermoplasty in Severe Persistent Asthma
Tacoma : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Vancouver : Investigational Site 904
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Wisconsin
Milwuakee : Research Site
A clinical research study for asthmatics 12 years and over.
View More »
Greenfield : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Greenfield : Allergy Asthma & Sinus Center, S.C.
A Study of ARRY-502 in Patients With Persistent Asthma
Greenfield :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Greenfield : Teva Investigational Site 10570
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Greenfield : Teva Investigational Site 10170
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Greenfield : Investigational Site 806
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
LaCrosse : Investigational Site 823
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Madison : Asthma Allergy & Pulmonary Research
A Study of ARRY-502 in Patients With Persistent Asthma
Madison :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Madison : University of Wisconsin-Madison
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Madison : University of Wisconsin
Bronchial Thermoplasty in Severe Persistent Asthma
Madison : University of Wisconsin Madison Department of Asthma, Allergy and Pulmonary Clinical Research
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
Milwaukee : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Milwaukee :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Milwaukee : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
West Allis : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Argentina
Berazategui : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Buenos Aires : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Buenos Aires : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Buenos Aires : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Buenos Aires : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
View More »
Capital Federal : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Capital Federal : 205.456.54002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Capital Federal : 205.456.54008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Capital Federal : 205.456.54006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Ciudad Autonoma de Buenos Aire : Fundacion CIDEA, Sanatorio San Jose
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Ciudad Autonoma de Buenos Aire : Organización Médica de Investigación
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Ciudad Autonoma de Buenos Aire : Fundacion CIDEA, Sanatorio San Jose
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ciudad Autonoma de Buenos Aire : Organización Médica de Investigación
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ciudad Autonoma de Buenos Aires : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Ciudad Autónoma de Buenos Aires : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Ciudad Autónoma de Buenos Aires : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Ciudad de Buenos Aires : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Florencio Varela : 205.456.54003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
La Plata : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Mar Del Plata : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Mar del Plata : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Mar del Plata : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Mendoza : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Mendoza : 205.456.54005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mendoza : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Monte Grande : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Nueve de Julio : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Nueve de Julio : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Quilmes : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Quilmes-Buenos Aires : Centro Respiratorio Quilmes
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Ranelagh : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Rosario : Centro Respiratorio Infantil
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rosario : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Rosario : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Rosario-Santa Fe : Sanatorio Parque de Rosario
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rosario-Santa Fe : Sanatorio Parque de Rosario
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Salta : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
San Miguel de Tucuman : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
San Miguel de Tucumán : 205.456.54004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
San Miguel de Tucumán : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
San Miguel de Tucuman - Tucuma : Investigaciones en Patologias Respiratorias
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucuman - Tucuma : Centro Modelo de Cardiologia
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucuman - Tucuma : Centro Médico Dra De Salvo
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
San Miguel de Tucuman - Tucuma : Centro Médico Dra De Salvo
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santa Fe : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Tucumán : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Australia
Brisbane :
A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Clayton : Monash Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Daw Park : Repatriation General Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Frankston : Frankston Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Herston : 205.456.61003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
View More »
Liverpool : Liverpool Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Melbourne : The Alfred Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nedlands :
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Nedlands : Lung Institute of Western Australia Inc
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nedlands : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Nedlands : GSK Investigational Site
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Nedlands : GSK Investigational Site
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
New Lambton : GSK Investigational Site
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Parkville : 205.456.61002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Perth :
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Perth : 205.456.61001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Austria
Feldbach : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Linz : 205.441.43003 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Linz : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Schlüsslberg : 205.441.43004 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Schlüßlberg : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
Thalheim bei Wels : 205.441.43001 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Thalheim bei Wels : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Vienna : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Wels : 205.441.43002 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Belgium
Antwerp :
A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16
Brussel : 205.443.01002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Brussels : GSK Investigational Site
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
Bruxelles : Hôpital Erasme
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bruxelles : Cliniques Universitaires Saint-Luc
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Bruxelles : Hôpital Erasme
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bruxelles : Cliniques Universitaires Saint-Luc
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Edegem (Antwerp) : University Hospital of Antwerp
Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients
Gent : UZ Gent
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Gent : UZ Gent
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Hasselt : 205.443.01003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Jambes : Docteur Jean-Benoit Martinot
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Liège : CHU de Liège
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Liège : CHU de Liège
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brazil
Belo Horizonte : Santa Casa de Belo Horizonte
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Belo Horizonte : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Florianopolis : Nucleo de Pesquisa em Asma e Inflamaçao das Vias Aereas
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Florianopolis : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Goiânia : Hospital Geral de Goiânia
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Porto Alegre : Hospital de Clínicas de Porto Alegre
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Santa Casa de Porto Alegre
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Hospital Nossa Senhora da Conceição
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Hospital São Lucas da PUC - RS
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Hospital Nossa Senhora da Conceição
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Hospital São Lucas da PUCRS
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Porto Alegre - RS : Hospital Moinhos de Vento
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre, RS : Irmandade da Santa Casa de Misericordia de Porto Alegre
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Porto Alegre-RS : Hospital de Clinicas de Porto Alegre
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rio de Janeiro : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Salvador : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Santo André, São Paulo : Fundação do ABC - Faculdade de Medicina do ABC
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Santo André, São Paulo : Fundação do ABC - Faculdade de Medicina do ABC
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Sao Paulo : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Vitoria : CEDOES- DIagnóstico e Pesquisa do Espírito Santo
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bulgaria
Burgas : Teva Investigational Site 59107
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Gotse Delchev : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Lovech : Teva Investigational Site 59103
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Petrich : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Pleven : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
View More »
Pleven : Teva Investigational Site 59106
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Plovdiv : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Plovdiv : 205.456.35902 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Ruse : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Ruse : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Ruse : Teva Investigational Site 59104
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Ruse : 205.456.35901 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Sofia : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Sofia : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Sofia : Teva Investigational Site 59105
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sofia : Teva Investigational Site 59101
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sofia : Teva Investigational Site 59102
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Sofia : 205.456.35903 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Sofia : 205.445.35901 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Sofia : 205.445.35902 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Sofia : 205.445.35903 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Sofia : 205.445.35904 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Canada
Alberta : Calgary Clinical Site 540
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
Brampton : Novartis Investigative Site
Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma
Calgary :
A Non-drug Study Profiling Asthma
Calgary : University of Calgary
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Calgary : University of Calgary
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Calgary : Research Site
Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma
Calgary : GSK Investigational Site
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Edmonton : University of Alberta Hospital
Tiotropium for Smoking Asthmatics Study
Hamilton : Joseph Greenbaum, MD
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Hamilton : Research Site
Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma
Kirkland : Merck Frosst Canada Ltd. Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Kirkland : Merck Frosst Canada Ltd. Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Markham : Lynderm Research
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Missassauga : Cheema Research, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Mississauga : GSK Investigational Site
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Montreal : Hopital du Sacre Couer de Montreal
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Montreal : Montreal Chest Institute
Bronchial Thermoplasty in Severe Persistent Asthma
Montreal : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Montreal : GSK Investigational Site
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
Newmarket : SKDS Research Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Newmarket : SKDS Research Inc.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Niagara Falls : Niagara Clinical Research
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Ontario : Hamilton Clinical Site 550
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
Ottawa : Ottawa Allergy Research Corp
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Ottawa : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Pointe-Claire : Dynamik Research, Inc.
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Pointe-Claire : Dynamik Research
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quebec : Research Site
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
Quebec : Centre De recherche Appliquee en Allergie DeQuebec
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Quebec : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Quebec City : Quebec Clinical Site 510
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
Quebec City : GSK Investigational Site
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
Sainte Foy :
A Non-drug Study Profiling Asthma
Sainte-Foy : Hospital Laval Centre de Pneumologie
Bronchial Thermoplasty in Severe Persistent Asthma
Sainte-Foy : Research Site
Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma
Saskatoon : Saskatoon Clinical Site 520
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
Saskatoon : Research Site
Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma
St-Charles-Borromée : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Surrey : Surrey Memorial Hospital
Bronchial Thermoplasty in Severe Persistent Asthma
Toronto : Primary Care Lung Clinic
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Toronto : Pulmonary Care Clinic
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
Toronto : GSK Investigational Site
A Study to Investigate the Safety, Pharmacodynamics and Efficacy Against Allergic Reactivity of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies
Toronto : The Hospital for Sick Children
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
Trois Rivieres : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Vancouver :
A Non-drug Study Profiling Asthma
Vancouver : Vancouver Clinical Site 530
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
Vancouver : Research Site
Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma
Windsor : Dr. Anil Dhar Professional Medicine Corporation
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Windsor : Dr. Anil Dhar Professional Medicine Corporation
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Windsor : Windsor Clinical Research
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Chile
Puente Alto - Santiago : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Quillota : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Rancagua : Hospital Regional Rancagua
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Santiago : Hospital Padre Hurtado
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Santiago : Investigaciones Medicas Tasol
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : Hospital Roberto del Rio
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Santiago : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Santiago : 205.444.56002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Santiago : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Santiago : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Talca : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Temuco : Centro Investigacion Clinica del Sur
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Valdivia : Hospital Base de Valdivia
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Valparaiso : Hospital Carlos Van Buren
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Valparaiso : GSK Investigational Site
Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
Viña del Mar : 205.444.56001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Viña del Mar : 205.444.56003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
China
Beijing : Capital Institute of Pediatrics
Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children
Beijing : The Second Artillery General Hospital of PLA
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Beijing : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Beijing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Beijing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
View More »
Changchun : GSK Investigational Site
Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation
Changchun : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changsha : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Changsha City : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Chengdu : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Chongqing : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Chongqing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Foshan : The First Affiliated Hospital of Foshan
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guang zhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Guang Zhou City : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Guangzhou : Guangzhou Institute of Respiratory Disease
Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma
Guangzhou : The First Affiliated Hospital of Guangzhou Medical College, Guangzhou Institute of Respiratory Disease
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guangzhou : Guangzhou First Municipal People's Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Guangzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Haikou : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Haikou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Hang Zhou : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Hangzhou : GSK Investigational Site
Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
Hangzhou : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Hangzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanchang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanjing : Zhongda Hospital of Southeast University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Nanjing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanjing : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Nanning : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Qingdao : GSK Investigational Site
Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
Qingdao : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shanghai : GSK Investigational Site
Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation
Shanghai : Dongfang Hospital Affiliated to Tongji University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : Zhongshan Hospital affiliated to Fudan University
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : Putuo District Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shanghai : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shanghai : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shanghai : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shengyang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shenyang : GSK Investigational Site
Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation
Shenyang : Shengjing Hospital
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shenyang : The General Hospital of Shenyang Military Region
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Shenyang : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shenyang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Shenzhen : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Shijiazhuang : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Suzhou : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Wenzhou : GSK Investigational Site
Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation
Wuhan : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Xian : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Xian : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Xi'an : Novartis Investigative Site
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Yinchuan : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Zhanjiang : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Colombia
Armenia : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Barranquilla : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Barranquilla : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bogota : Frosst Laboratories Inc.
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)
Bogota : Fundación Salud Bosque
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Bogota : Fundación Salud Bosque
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogota : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Bogota : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Bogota : Frosst Laboratories Inc. Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Bogotá : Fundacion Neumologica Colombiana
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogotá : Fundacion Neumologica Colombiana
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bogotá : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Cali : Fundacion Clinica Valle del Lili
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Floridablanca : Fundacion Oftalmologica de Santander Foscal
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Floridablanca : Fundacion Oftalmologica de Santander Foscal
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Croatia
Split : Teva Investigational Site 85105
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Zagreb : Teva Investigational Site 85102
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Zagreb : Teva Investigational Site 85103
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Zagreb : Teva Investigational Site 85104
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Czech Republic
Beroun : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Boskovice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Breclav : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Breclav : Alergologicka ambulance
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Breclav : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
View More »
Brno : HORNMED s.r.o.
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Brno : HORNMED s.r.o.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Brno : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Brno - Bohunice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Hradec Kralove : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jablonec nad Nisou : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jihlava : 205.446.42001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Jindřichův Hradec : Sdružená pneumologická a anesteziologická ambulance
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Kladno : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Krnov : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Kutna Hora : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Kutna Hora : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Liberec : Krajska nemocnice Liberec
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Liberec : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Litomerice : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Most : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Olomouc : Fakultni Nemocnice
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ostrava : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Ostrava : Fakultni nemocnice
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ostrava-Marianske Hory : Alergologie Skopkova s.r.o
Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients
Plzen : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Plzen : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Plzen - Bory : Fakultni nemocnice
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Prague : 205.446.42002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Prague : 205.446.42004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Praha : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Praha : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Rokycany : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Tabor : KASMED s.r.o.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tabor : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Teplice : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Trutnov : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Denmark
Aarhus C : Research Dept. of Respiratory Medicine, Aarhus University Hospital
Daily Magnesium-supplement for Severe Asthmatics
Copenhaghen : BorneAstmaKlinikken
Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old
Hvidovre : Hvidovre Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kobenhavn Nv :
A Non-drug Study Profiling Asthma
Odense : Odense universitetshospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Finland
Helsinki : 205.443.02002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Turku : 205.443.02003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
France
Beuvry : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Bordeaux Pessac N/A :
A Non-drug Study Profiling Asthma
Grenoble : CHU de GRENOBLE
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lille cedex : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Lyon cedex 04 : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
Lyon cedex 04 : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Marseille :
A Non-drug Study Profiling Asthma
Marseille : CHU Nord
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Marseille cedex 20 : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Montpellier : Hôpital Arnaud de Villeneuve
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Montpellier : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Montpellier : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Montpellier : CHU Arnaud de Villeneuve
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
Montpellier cedex 5 : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Perpignan : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Perpignan : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Reims : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Saint Pierre cedex : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Strasbourg Cedex : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Tarbes Cedex : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Germany
Bad Wörishofen : Praxis Dr. med. Junggeburth
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Praxis Dr. Anneliese Linnhoff
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Klinische Forschung Berlin Mitte GmbH
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Charité - Universitätsmedizin Berlin
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Berlin : Hautarztpraxis
Depigoid Birch 5000 Longterm Study in Adults and Adolescents
View More »
Berlin : Hippke, Ear-Nose-Throat specialist
Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
Berlin : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Berlin : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Berlin : 205.456.49008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Berlin : 205.445.49015 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Berlin : 205.445.49012 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Berlin : 205.446.49015 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Berlin : 205.446.49012 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Berlin : 205.444.49007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Berlin : 205.444.49008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Berlin : 205.443.03003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Berlin : Charité Research Organisation GmbH
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
Bochum : 205.456.49001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Bochum : 205.445.49001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Bochum : 205.446.49001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Bochum : 205.444.49001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Bochum : 205.443.03001 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Bonn : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Dresden : Synexus Clinical Research GmbH
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Dresden : 205.445.49007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Dresden : 205.446.49007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Elgershausen. Greifenstein : Lungenfachklinik Waldhof Elgershausen
Inhaled Steroids and Control of Severe Asthma
Ettenheim : 205.445.49004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Ettenheim : 205.446.49004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Ettenheim : 205.444.49003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Ettenheim : 205.443.03002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Frankfurt :
A Non-drug Study Profiling Asthma
Frankfurt : IKF Pneumologie
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Frankfurt : 205.441.49014 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Frankfurt : 205.441.49003 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Frankfurt : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Frankfurt : 205.456.49004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Frankfurt : 205.445.49003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Frankfurt : 205.446.49003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Frankfurt : Clinical Research Centre RespiratoryMedicine (IKF)
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
Frankfurt am Main : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Gauting : Inamed GmbH
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
Geesthacht : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Giessen : Justus-Liebig-University Giessen
Inhaled Steroids and Control of Severe Asthma
Großhansdorf : 205.441.49007 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Grosshansdorf : Pulmonary Research Institute (PRI)
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
Grosshansdorf : Novartis Investigative Site
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
Haar : Msd Sharp & Dohme Gmbh Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Haar : Msd Sharp & Dohme Gmbh Updated
Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM1)
Hamburg : Hamburger Institut für Therapieforschung GmbH
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Hamm : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Hannover : 205.441.49005 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Hannover : Clinical Airway Research Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
Hannover : Novartis Investigative Site
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
Jena : 205.456.49009 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Jena : 205.445.49005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Jena : 205.446.49005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Kehl : 205.456.49005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Kehl : 205.445.49008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Kehl : 205.446.49008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Kleve-Materborn : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Koblenz : Pneumologische Schwerpunktpraxis Kroker, Schaeben, Schmidt
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Koblenz : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Koblenz : 205.456.49003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Koblenz : 205.445.49009 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Koblenz : 205.446.49009 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Koblenz : 205.444.49006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Landsberg : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Leipzig : Synexus ClinPharm GmbH
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Leipzig : 205.441.49004 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Lübeck : 205.441.49010 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Magdeburg : GSK Investigational Site
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
Magdeburg : GSK Investigational Site
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Mainz : Studienzentrum Mainz Mitte am GesundheitsCentrum Mainz
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mainz : Universitätsmedizin der Johannes Gutenberg-Universität Mainz
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mainz : 205.456.49010 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mainz : Johannes Gutenberg University Medical Clinic III for Hematology, Oncology and Pneumology
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
Mainz : Novartis Investigative Site
Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
Mannheim : 205.441.49013 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Marburg : 205.445.49014 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Marburg : 205.446.49014 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Mönchengladbach : 205.445.49011 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Mönchen-Gladbach : 205.456.49006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mönchen-Gladbach : 205.446.49011 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Neu-Isenburg : 205.441.49001 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Neu-Isenburg : 205.456.49007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Neu-Isenburg : 205.445.49002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Neu-Isenburg : 205.446.49002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Oberhausen : 205.445.49013 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Oberhausen : 205.446.49013 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Rosenheim : 205.444.49005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Rosenheim : 205.443.03008 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Rüdersdorf : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Schwetzingen : Nycomed Investigational Site
Effect of High Dose Ciclesonide on Asthma Control
Wesel : 205.456.49002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Wiesbaden : 205.441.49002 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Wiesbaden : Zentrum für Rhinologie und Allergie
Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
Wiesbaden : insaf - Respiratory Research Institute GmbH
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
Wiesloch : 205.441.49011 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Wolfenbuettel : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Greece
Alexandroupolis : University General Hospital of Alexandroupolis
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Athens : Sotiria Chest hospital of Athens
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Athens : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Heraklion, Crete : University General Hospital of Heraklion
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Heraklion/ Crete : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
Larissa : University Hospital of Larissa
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Thessaloniki : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Guatemala
Antigua Guatemala : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Guatemala : 205.445.50201 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Guatemala City : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Hungary
Ajka : 205.446.36002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Ajka : 205.444.36007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Balassagyarmat : Dr. Kenessey Albert Kórház-Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Balassagyarmat : Dr. Kenessey Albert Kórház-Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Balassagyarmat : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
Balassagyarmat : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Budapest : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Budapest : Teva Investigational Site 36104
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Budapest : 205.456.36005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Budapest : 205.446.36001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Budapest : 205.444.36005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Budapest : 205.444.36008 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Cegled : 205.441.36003 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Csoma : Teva Investigational Site 36514
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Debrecen : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Debrecen : University of Debrecen Medical and Health Science Center
A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids
Debrecen : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Debrecen : 205.456.36002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Debrecen : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Deszk : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Deszk : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Godollo : 205.441.36002 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Gyor : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Gyor : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Gyor : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Gyula : 205.456.36004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Kaposvar : 205.444.36006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Kiskunhalas : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Kiskunhalas : Illés és Ádám Egészségügyi Szolgáltató Bt.
Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients
Marcali : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Miskolc : Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi O
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Miskolc : Miskolci Semmelweis Ignác Egészségügyi Központ és Egyetemi O
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Miskolc : 205.456.36001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Miskolc : 205.444.36001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Mosdos : 205.456.36007 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mosdos : 205.444.36002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Mosonmagyarovar : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Mosonmagyarovar : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Mosonmagyaróvár : Karolina Kórház Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Mosonmagyaróvár : Karolina Kórház Rendelöintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Nagyatad : 205.456.36006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Nagyatad : 205.446.36003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Nyiregyhaza : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Nyiregyhaza : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Nyiregyhaza : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Pecs : 205.441.36001 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Sopron : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Sopron : Sopron Megyei Jogú Város Erzsébet Kórház a DEOEC Oktató Kórh
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Sopron : Sopron Megyei Jogú Város Erzsébet Kórház a DEOEC Oktató Kórh
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Szazhalombatta : 205.441.36005 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Százhalombatta : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Szeged : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Szeged : Teva Investigational Site 36506
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Szigetbecse : 205.444.36004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Szigetszentmiklos : 205.441.36004 Boehringer Ingelheim Investigational Site
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
Szigetvar : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Tatabanya : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Tatabánya : Komárom-Esztergom Megyei Önkormányzat Szent Borbála Kórháza
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Torokbalint : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Torokbalint : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Torokbalint : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Törökbálint : Pest Megyei Tüdögyógyintézet
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Veszprem : Teva Investigational Site 36512
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Zalaegerszeg : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
India
Ahmedabad : Gujarat Pulmonary & Critical Care Clinic
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Ahmedabad : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Bangalore : Chest and Maternity Centre
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bangalore : M S Ramaiah Medical College & Teaching Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bangalore : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
Chennai : Chennai Thoracic Research Institute
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Chennai : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Chennai : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Coimbatore : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Goa : T B and Chest Disease Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Hyderabaad : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Hyderabad : Kunal Institute of Medical Specialities Pvt. Ltd
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Indore : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Indore : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Jaipur : Asthma Bhawan
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Jaipur : Dr Khippal's Clinic
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Jaipur : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kolkata : National Allergy Asthma Bronchitis Institute
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Ludhiana : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Mangalore : Kasturba Medical College Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Mangalore : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Mumbai : The Bhatia Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Mumbai : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Mysore : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Nagpur : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Nagpur : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Nagpur - Maharashtra : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Nellore : Narayana Medical College & Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Panjim : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Panjim : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Ponda : Rutuja Allergy , Chest and General Clinic
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Pune : Chest Research Foundation
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Pune : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Secunderabad : Yashoda Hospital
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Tamil Nadu : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Vellore : Christian Medical College
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Israel
Ashkelon : Teva Investigational Site 72511
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
Ashkelon : Teva Investigational Site 72111
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Ashkelon : Barzilai Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Beer-Sheva : Soroka University Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Haifa : Teva Investigational Site 72101
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
View More »
Haifa : The Lady Davis Carmel Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Haifa : Regional Pulmonary Clinic, Clalit Health Services
Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)
Holon : 205.456.97205 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Jerusalem : Teva Investigational Site 72102
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Jerusalem : Teva Investigational Site 72104
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Jerusalem : Shaare Zedek Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Jerusalem : Hadassah University Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kfar Saba : Teva Investigational Site 72109
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Kfar Saba : Meir Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Petach Tikva : Rabin Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Petach Tikva : 205.456.97203 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Ramat Gan : Chaim Sheb Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Ramat-Gan : Teva Investigational Site 72107
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rehovot : Teva Investigational Site 72103
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Rehovot : Kaplan Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Rehovot : Kaplan Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tel Aviv : Teva Investigational Site 72110
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Tel-Aviv : Tel Aviv Sourasky Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tel-Aviv : Tel Aviv Sourasky Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Zerifin : Teva Investigational Site 72105
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
Italy
Bologna : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Catanzaro : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Cittadella PD : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Ferrara : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Ferrara : Research Centre on Asthma and COPD, University of Ferrara
Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study
View More »
Firenze : Azienda Sanitaria Firenze Piero Palagi
International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)
Genova : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Genova : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Milan : Merck Sharp & Dohme (Italia) S.P.A. Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Padova : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Palermo : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Parma : Dipartimento Cardio-Polmonare - Azienda Ospedaliero-Universitaria - Padiglione Rasori
A Study in Patients With Asthma
Parma : Clinica Pneumologica, AOU di Parma
An Open Label Placebo Study to Assess the Inhalation Profile in Asthmatic Patients Using the Nexthaler® Dry Powder Inhaler (DPI) Device
Pietra Ligure (SV) : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Pisa : Cardio-Thoracic and Vascular Dept, University of Pisa
Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients
Pisa : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Roma : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Japan
Asahikawa : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Chiba : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Chuo-ku : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Fukuoka : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Fukuoka-city : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
View More »
Hamamatsu : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Higashiibaraki-gun : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Himeji-city : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Hiroshima : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Hiroshima : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Hokkaido : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Hokkaido : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Hyogo : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Itabashi : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kagawa : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Kanazawa : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kasuga-city : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kawasaki : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kishiwada : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kitakyushu : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kiyose-city : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kochi : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Kyoto : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Minato-ku : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Mizunami :
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom
Nishio-city : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Osaka : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Sagamihara : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Sakaide : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Sapporo : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Sapporo-city : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Tachikawa : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Tokyo : MSD K.K. Updated
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM1)
Tokyo : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Tsukubo-gun : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Wakayama : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Yanagawa : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Yokohama-city : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Korea, Republic of
Ansan-si : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Anyang-Si : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Bucheon-si, : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Busan : 205.444.82005 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Cheonan : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
View More »
Cheongju : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Cheongju, Chungcheongbuk-do : GSK Investigational Site
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
Cheongju, Chungcheongbuk-do : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Cheongju, Chungcheongbuk-do : GSK Investigational Site
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Guri : 205.444.82003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Guri-si : 205.443.82003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Gwangju : Chonnam National University Hospital Institutional Review Bo
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Gwangju : Novartis Investigative Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Ilsanseo-gu, Goyang-si, Gyeonggi-do : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Incheon : 205.444.82006 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Incheon : 205.443.82002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Jinju : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Pusan : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Seongnam-si : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Seongnam-si, Gyeonggi-do : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Seoul : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Seoul : Severance Hospital Institutional Review Board
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Kangdong Sacred Heart Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Asan Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Korea University Guro Hospital IRB
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Seoul National University Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Seoul : Seoul National University Hospital
Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma
Seoul : 205.444.82004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Seoul : 205.444.82001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Seoul : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Seoul : 205.443.82004 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Seoul : Seoul St. Mary's Hospital of the Catholic university of Korea
Safety and Efficacy of SA09012 in Asthma
Seoul : Yuhan Corporation
Safety and Efficacy of YHD001 in Asthma
Seoul : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seoul : Novartis Investigative SIte
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Seoul : Samsung medical center
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul : Seoul National University
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul : Asan Medical Center
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul : Hanyang University Hospital
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Seoul, : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Suwon : Ajou University Hospital Institutional Review Board
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Suwon : Ajou University Medical Center
Asthma Control in Elderly Patients With Montelukast
Suwon : Ajou University Hospital
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
Suwon, Kyonggi-do : GSK Investigational Site
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Latvia
Adazi : 205.445.37104 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Baldone : 205.456.37101 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Baldone : 205.445.37101 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Baldone : 205.446.37105 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Baldone : 205.444.37101 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
View More »
Balvi : 205.456.37104 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Balvi : 205.445.37106 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Balvi : 205.446.37104 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Balvi : 205.444.37107 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Balvi : 205.443.05001 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Daugavpils : 205.446.37108 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Jekabpils : 205.446.37107 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Ogre : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Ogre : 205.445.37102 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Ogre : 205.446.37101 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Ogre : 205.444.37102 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Rezekne : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Rezekne : 205.456.37103 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Rezekne : 205.445.37107 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Rezekne : 205.446.37106 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Rezekne : 205.444.37105 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Rezekne : 205.443.05003 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Riga : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Riga : 205.456.37102 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Riga : 205.445.37103 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Riga : 205.445.37105 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Riga : 205.446.37102 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Riga : 205.446.37103 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
Riga : 205.444.37106 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Riga : 205.443.05002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Talsi : 205.456.37105 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Talsi : 205.444.37103 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Tukums : 205.444.37104 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Malaysia
Batu Caves : Universiti Teknologi Mara
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kelantan : 205.443.10002 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Kuala Lumpur : University Malaya Medical Centre
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kuala Lumpur : Universiti Kebangsaan Malaysia Medical Centre
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Kuala Lumpur : 205.443.10001 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
View More »
Kuantan : Hospital Tengku Ampuan Afzan
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Penang : Hospital Pulau Pinang
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Taiping : Taiping Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Mexico
Distrito Federal : Instituto Nacional de Pediatría
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Distrito Federal : Médica Sur, S.A.B. de C.V.
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Distrito Federal : Instituto Nacional de Pediatría
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Distrito Federal : Médica Sur, S.A.B. de C.V.
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Durango : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
View More »
Guadalajara : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Guadalajara : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Guadalajara : 205.444.52002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Guadalajara, JAL : Instituto Jalisciense de Investigacion Clinica
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Guadalajara, JAL : Instituto Jalisciense de Investigacion Clinica
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Hermosillo : 205.444.52001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Hermosillo Sonora : 205.456.52001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Mexicali : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Mexico : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
México : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Mexico City : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Mexico City, Distrito Federal : Hospital Angeles Lindavista
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Mexico City, Distrito Federal : Hospital Angeles Lindavista
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Monterrey : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Monterrey : Hospital Universitario - Dr. José Eleuterio Gonzalez
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Monterrey : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Monterrey : 205.456.52002 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Monterrey : 205.456.52003 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Morelia : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Morelia : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Nuevo León : 205.456.52004 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Puebla, Pue : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Sonora : Hospital General del Estado de Sonora
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Sonora : Hospital General del Estado de Sonora
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tijuana, B.C. : Operadora de Hospitales Angeles, S.A de C.V. (Hospital Angel
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Tijuana, B.C. : Operadora de Hospitales Angeles, S.A de C.V. (Hospital Angel
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Villahermosa : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Villahermosa : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Villahermosa : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Zapopan : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Zapopan : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Zapopan : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Zapopan : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Zapopan : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Netherlands
Almelo : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Almelo : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Amsterdam : GSK Investigational Site
Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
Amsterdam : Academic Medical Center
Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
Eindhoven : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
View More »
Groningen : University Medical Center Groningen
Development of Small Airway Disease Questionnaire
Groningen : 205.443.04001 Boehringer Ingelheim Investigational Site
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
Harderwijk : Novartis Investigative Site
Dose Finding Study for QAW039 in Asthma
Heerlen : Atrium MC
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Hoogwoud : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Zutphen : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
New Zealand
Auckland :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Dunedin :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Dunedin : RMC Medical Research Ltd
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Hamilton :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Hamilton : Waikato Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Otahuhu : Middlemore Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Rotorua : Hinemoa House Family Healthcare
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Tauranga : Bay of Plenty Medical Research Trust
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Wellington :
A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Wellington : Medical Research Institute of New Zealand
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Norway
Bergen : 205.456.47001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
Bergen : 205.444.47001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
Pakistan
Vehari : District Headquarters Hospital
Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health (ESS-EMCH) Training by Assessing the Doctors' Practices
Panama
Ciudad de Panama : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Peru
Cercado de Lima, Lima : Clinica Internacional
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Lima : Hospital Nacional Edgardo Rebagliati Martins
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Hospital Cayetano Heredia
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Clinica San Borja
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Lima : Complejo Hospitalario San Pablo
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Alfredo Berrocal Kasay Reuma Sociedad de Responsabilidad Lim
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Centro de Investigación Ricardo Palma
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : Hospital Nacional Luis N. de la Policia Nacional del Peru
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Lima : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Lima : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Lima : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Lima : Novartis Investigator Site
Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Lima 18 : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Lima 27 : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Borja : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
San Miguel : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
San Miguel : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
Santiago de Surco : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Philippines
Cebu City : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Davao City : Vectura Clinical Trial Site 31002
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Governor Mangubat Drive, Dasma : De La Salle University Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Iloilo City : Vectura Clinical Trial Site 31003
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Lipa City : Vectura Clinical Trial Site 31001
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
View More »
Manila : Philippine General Hospital
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Manila : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Marilao, Bulacan : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Pasig City : Vectura Clinical Trial Site 31004
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Quezon City : Quirino Memorial Medical Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : Lung Center of the Philippines
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : FEU-NRMF Medical Center, Bioethics Review Committee
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : Philippine Heart Center
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Quezon City : Vectura Clinical Trial Site 31005
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Quezon City : Vectura Clinical Trial Site 31007
Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
Quezon City : GSK Investigational Site
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
Quezon City : GSK Investigational Site
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
Poland
Bialystok : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Bialystok : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Bialystok : NZOZ 'Promedica'
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
Bialystok : Prywatny Gabinet Internistyczno-Alergologiczny
A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Bialystok : Prywatny Gabinet Internistyczno-Alergologiczny
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
View More »
Bydgoszcz : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Bydgoszcz : 10 Wojskowy Szpital Kliniczny z Poliklinika
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Bydgoszcz : GSK Investigational Site
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
Bystra : Specjalistyczny Zespol Chorob Pluc i Gruzlicy w Bystrej
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 Years of Age) With Eosinophilic Asthma
Checiny : Research Site
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
Czestochowa : Research Site
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Debica : Poradnia Alergologiczna
Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
